Daily Stock List
SilverSun Technologies, Inc. (SSNT)
Bull Trends and FutureMoneyTrends reported on SilverSun Technologies, Inc. (SSNT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
SilverSun Technologies, Inc. is a business application, technology, and consulting company. It provides strategies and solutions to meet its clients' information, technology and business management needs. SWK Technologies, Inc. is SilverSun's principal operating subsidiary. In essence, SilverSun Technologies is a value added reseller of business application software. The Company lists on the OTC Bulletin Board. SilverSun is based in Livingston, New Jersey.
SilverSun Technologies, by way of SWK Technologies, offers services and technologies that enable customers to manage, protect, and monetize their enterprise assets whether on premise or in the "Cloud." The Company offers solutions for accounting and business management, financial reporting, Enterprise Resource Planning (ERP), Warehouse Management Systems, Customer Relationship Management and Business Intelligence.
It also has its own in-house development staff creating software solutions for Electronic Data Interchange, time and billing, and diverse ERP enhancements. The Company’s value-added services center on consulting and professional services, specialized programming, training, and technical support. SilverSun has a dedicated network services practice. It provides managed services, hosting, business continuity, cloud, e-mail, and also web services.
SilverSun Technologies is targeting to move the mass amount of business documents between companies from the physical to the digital world with its MAPADOC EDI solution. MAPADOC is, fundamentally, an electronic data interchange software.
In March, SilverSun Technologies announced that its wholly-owned subsidiary, SWK Technologies closed on the acquisition of Accounting Technology Resources (ATR). ATR has implemented technology solutions at well-known companies throughout California. ATR is a foremost California-based reseller of Sage Software and Acumatica applications.
Furthermore, in May, SilverSun Technologies announced that SWK Technologies signed a Letter of Intent (LOI) to acquire ProductiveTech, Inc. (PTI). PTI is a New Jersey-based managed service provider (MSP). PTI provides 24/7/365 remote network monitoring, data backup, business continuity, and cloud computing services.
Additionally, in May, SilverSun Technologies announced record Q1 financial results for the three months ended March 31, 2015. Total revenues increased 31.6 percent to $6,483,114 from $4,924,625. Earnings before interest, taxes, depreciation and amortization (EBITDA) was $669,923. This is up from $279,375, an increase of 140 percent.
Income from operations totaled $557,967, up from $201,642. This represents an increase of 177 percent. Operating margins increased to 8.6 percent, up from 4.1 percent. Net income was $521,167, or $0.13 earnings per basic share, an increase from net income of $120,741, or $0.03 earnings per basic share.
Yesterday, SilverSun Technologies announced the launch of its new corporate website. (www.silversuntech.com
). The design of the new site is to provide visitors with meaningful insight and perspective on SilverSun Technologies’ growing business platform. The site features intuitive navigation, video, complete information about the Company’s service offerings and user friendly support resources relevant to shareholders, prospective investors, and potential new business partners looking for information on SilverSun.
SilverSun Technologies, Inc. (SSNT), closed Friday's trading session at $4.101, up 1.26%, on 1,450 volume with 4 trades. The average volume for the last 60 days is 2,093 and the stock's 52-week low/high is $1.86/$9.135.
Searchlight Minerals Corp. (SRCH)
SmarTrend Newsletters reported previously on Searchlight Minerals Corp. (SRCH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Searchlight Minerals Corp. engages in the acquisition and exploration of mineral properties and slag reprocessing projects. An exploration stage company, it is centering on the acquisition and development of projects in the southwestern U.S. The Company holds interests in the Clarkdale Slag Project. Searchlight Minerals lists on the OTCQB and the Company has its corporate headquarters in Henderson, Nevada.
The Clarkdale Slag Project is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona. The Project is located in Clarkdale, Arizona.
In May 2014, Searchlight Minerals announced significant technical achievements in gold and iron recovery at its Clarkdale Slag Project. The achievements include, but are not limited to, the determination of precise nature of the gold contained in the slag material; the addition of a high temperature pre-treatment step, which aids in the recovery of the gold and provides a saleable iron by-product; and up to a 60 percent extraction of metallic gold from fire assay of ion exchange resin. Searchlight’s belief is that the project is commercially viable, if repeatable, at current results, based on these achievements.
The Company previously had its Searchlight Gold Project mining claims. Effective September 2, 2014, it allowed its Searchlight Gold Project mining claims, comprising non-patented placer mining claims situated on federal land administered by the United States Bureau of Land Management (BLM), to lapse by declining to pay the related BLM and Clark County, Nevada maintenance fees.
The claims were made up of 20 one hundred and sixty acre parcels on a 3,200 acre site near Searchlight, Nevada. They were also made up of one hundred and forty two
20 acre claims that were "double staked" on top of the 3,200 acre site. These claims have not been a major focus of the Company’s business strategy since its acquisition of the Clarkdale Slag Project in 2007.
Searchlight Minerals expects to save roughly $48,518 per year in annual claim maintenance fees through allowing the mining claims to lapse. It believes the funds will be better spent in furtherance of the Clarkdale Slag Project. The Company is continuing its autoclave testing and optimization of gold recovery. It is moving towards commercial operation and project feasibility. Regarding the current work program at the Clarkdale Slag Project, Searchlight Minerals is now working on pre-treatment, optimization testing, vendor estimates, and personnel.
Searchlight Minerals Corp. (SRCH), closed Friday's trading session at $0.24, up 1.05%, on 55,500 volume with 8 trades. The average volume for the last 60 days is 39,491 and the stock's 52-week low/high is $0.165/$0.55.
Inergetics, Inc. (NRTI)
Pennybuster, SmallCapVoice, and Zacks reported on Inergetics, Inc. (NRTI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Inergetics, Inc. is a foremost developer of patented nutritional products consisting of high-quality ingredients and proprietary formulations. It has targeted brands that independently serve the Clinical Nutrition, Long Term Care (Senior Care), and Sports Nutrition Markets. Inergetics has entered into a strategic partnership with Terra Tech Corp. (TRTC) to jointly develop a line of natural Cannibidiol based nutritional supplements. Terra Tech is an urban agricultural company. OTCQB-listed Inergetics is based in Newark, New Jersey.
The Company’s brand portfolio features Martha Stewart Essentials™. This is a complete line of whole-food based supplements created expressly for women, developed in association with Martha Stewart herself. In addition, Inergetics’ brands include Bikini Ready®. Bikini Ready® is its complete line of weight loss lifestyle products. Bikini Ready® products include Weight Loss Catalyst, Fashion Multi, Cleanse, and Yummy Shake Flavors, all purposely designed for women.
Additionally, the Company’s brands include Surgex® Sports Nutrition. This is the preferred nutritional supplement of Army Sports. Its Surgex® Sports Nutrition is a clinically studied performance enhancing formula. The design of it is to build lean muscle and increase energy to realize top levels of power and stamina. Surgex® Sports Nutrition features novel formulas developed to meet the nutritional needs of the masses and amateur and professional athletes.
Moreover, Inergetics offers its OmEssentials®. This is a line of scientifically advanced nutritional supplements designed to further the health and wellness of yoga practitioners and active individuals. Inergetics also offers SlimTrim™. This is an affordable, premium value diet brand. The formulation of SlimTrim™ is to work with one’s body naturally in combination with diet and exercise. The design of SlimTrim™ is to help one lose weight, burn fat, stimulate metabolism, cleanse, and curb appetite.
Inergetics has launched a new product called Nulief™. This is a branded nutritional supplement offering the holistic benefits associated with Cannabidiol (CBD). Nulief™ is the first nutraceutical in a line of products undergoing development by Inergetics' new Whole Products® division to offer consumers the convenient benefits of non-psychoactive CBD.
Recently, Inergetics announced it formalized a partnership to represent sales and marketing for the Nulief™ CBD brand. The partnership established to develop and execute potential distribution when the brand transitions from "test & learn" in dispensaries to mainstream sales channels. Nulief is the first branded CBD supplement line. It is now in test market at dispensaries.
Inergetics, Inc. (NRTI), closed Friday's trading session at $0.0013, up 85.71%, on 175,528,676 volume with 396 trades. The average volume for the last 60 days is 10,325,741 and the stock's 52-week low/high is $0.0007/$0.095.
KollagenX Corp. (KGNX)
HotStockProfits, Value Penny Stocks, PennyPickAlerts, Fortune Stock Alerts, ThePUMPTracker, Penny Stock Circle, StockMister, 1-2-3 Stock Alerts, The Stock Psycho, Darth Trader, PREPUMP STOCKS, Damn Good Penny Picks, Penny Picks, and Penny Stock Newsletter reported recently on KollagenX Corp. (KGNX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 2007, KollagenX Corp. is an advanced skin care development and marketing enterprise. Its chief focus is nano gold technology, also called NGT®. KollagenX® develops and introduces new, safe, more affordable eco-friendly NGT® products that it believes will help improve the quality of lives. KollagenX is headquartered in Chino Hills, California. The Company formerly went by the name Integrated Electric Systems Corp. It changed its name to KollagenX Corp. in July 2014.
KollagenX® helps bring the nourishment one’s skin requires to be healthier and function more effectively. The Company indicates that its innovative anti-aging skin care products restore a natural youthful glow and a smoother, suppler appearance.
KollagenX® Nano Gold Technology (NGT®) has recognition for its ability to ward off UV damage, tighten lax skin, and reduce the appearance of discoloration spotted skin. This is in addition to its antioxidant and antimicrobial abilities. KollagenX® (NGT®) promotes increased circulation, assists in eliminating toxins from the body, and speeds up tissue repair. It promotes the growth of the skin cells through replacing the aging cells for revitalization.
KollagenX’s Collection includes 24KT Gold Face Mask, 24KT Gold Under-Eye’s, 24KT Gold Eye Serum, 24KT Gold Hydrating Cream, 24KT Gold Cleanser, and 24KT Gold Lip Gloss. KollagenX Nano Gold is 99.999 percent pure gold, and is free of any hazardous metal elements. Additionally, it is 1/2000 the size of an average pore, therefore easily penetrating into the dermis. KollagenX® has received approval for their 24KT Nano Gold product line from the Ministry of Health of Kuwait. Approval was granted to import product to Kuwait.
This month, KollagenX® management engaged Mega World Media to expand the Company website for exposure with social media and over all branding of its 24k Gold Cosmetic Collection. Mega World Media is an international strategic marketing company. It has expertise in social media, web design, public relations, SEO marketing, as well as film production.
KollagenX Corp. (KGNX), closed Friday's trading session at $0.34, up 5.92%, on 66,281 volume with 16 trades. The average volume for the last 60 days is 73,531 and the stock's 52-week low/high is $0.16/$1.01.
Definitive Rest Mattress Company (DRMC)
Juicy Penny Stocks, PennyStocks24, Pumps and Dumps, Penny Stocks VIP, FatCat Stocks, Penny Pick Insider, Daily Stock Motion, SMS Penny Picks, Wall Street Beauties, and WINNINGOTC reported earlier on Definitive Rest Mattress Company (DRMC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Definitive Rest Mattress Company (DRMC) formerly engaged in the manufacturing and sales of mattresses. This year, it has embarked upon a change of business direction into the Aerospace and Industrial Metals Sector. The Company’s new customer base and new product line has opened the doors to numerous opportunities in the Aerospace, Defense and Commercial component manufacturers, Domestic and International sectors.
DRMC’s shares trade on the OTC Markets Group’s OTCQB. An Oklahoma corporation, the Company has its corporate headquarters in Southern California.
BY the end of Q2 of 2015 the Company completed its transformation to its new Metals and Machine Tool operations for the Aerospace and Mold manufacturing industry sectors. Its’ growth plans call for it to acquire or develop entrepreneurial companies and operations with strong growth business plans and profit potential in such industry sectors. DRMC’s new executive management team are on pace to meet its revenue projections for Q3 of 2015.
DRMC has been redesigning its business operations through acquiring NU Metals Technology as a provider of Hi-grade metals and tooling solutions for the manufacturing of aerospace part components. DRMC’s new executive management team is organizing operations for the Metals and Machine Tool division by following NU Metals Technology’s business plan.
The Machine Tool division has the exclusive U.S. representation of ACCUT Machinery Ltd. ACCUT is a well-established international machine tool manufacturer. The Metals division is providing metals solutions to well recognized manufacturers in the Aerospace Industry.
At the end of March, Mr. Juan Carlos Murga, the Company's Chief Executive Officer, said, "We are very excited with the Company's rebirth into a vibrant new enterprise within the Metals Industry and Machine Tool industry that stretches across many lucrative sectors in manufacturing. We will leave the old operations behind and look forward to better growth potential and shareholder value with our new direction into these two sectors in Industry and Technology."
In addition, DRMC is working on completing its new web site. It will be its portal to showcase a comprehensive and varied product line for a worldwide customer base. Its product line includes Tooling and CNC Machinery solutions.
Definitive Rest Mattress Company (DRMC), closed Friday's trading session at $0.003, up 3.45%, on 1,320,748 volume with 30 trades. The average volume for the last 60 days is 308,379 and the stock's 52-week low/high is $0.0009/$0.018.
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $15.37, up 9.79%, on 9,588 volume with 47 trades. The stock’s average daily volume over the past 60 days is 609, and its 52-week low/high is $3.16/$15.37.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
Dr. Gerard Sanacora Joins VistaGen's Clinical and Scientific Advisory Board
VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
Galenfeha, Inc. (GLFH)
The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.30, up 15.38%, on 116,710 volume with 26 trades. The stock’s average daily volume over the past 60 days is 32,631, and its 52-week low/high is $0.1011/$4.00.
Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.
Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.
Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.
The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer
Galenfeha, Inc. Company Blog
Galenfeha, Inc. News:
Galenfeha Broadens Oil and Gas Industry Penetration
Lithium Iron Phosphate Battery Tech: Providing Better Performance and Environmental Sustainability
Lithium Iron Phosphate Battery Technology in Focus As Tesla Announces Disruptive Powerwall Home Battery
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0013, even for the day, on 8,702,202 volume with 40 trades. The stock’s average daily volume over the past 60 days is 5,405,449, and its 52-week low/high is $0.0013/$0.5882.
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
PURE Hospitality Solutions Releases Oveedia Site Snapshots
PURE Hospitality Solutions Teams Up With Jaco Tour Company
PURE Hospitality Solutions Accelerates Debt Reduction Program
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0465, up 1.09%, on 629,409 volume with 36 trades. The stock’s average daily volume over the past 60 days is 772,719, and its 52-week low/high is $0.045/$0.148.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting
International Stem Cell Corporation Announces 2015 First Quarter Results
International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.18, even for the day. The stock’s average daily volume over the past 60 days is 4,032, and its 52-week low/high is $0.0248/$0.20.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
LOANS4LESS.COM Enters into an Acquisition Agreement with 321LEND
Loans4Less.com, Inc. Enters into an Investment Banking Agreement with WestPark Capital, Inc. and Seeks Bank Strategic Partner for National Mortgage Broker Origination and Brand Exposure Opportunity
Loans4Less.com Seeks a Merger, Joint Venture Partner and/or Investor for National Loan Origination and Brand Exposure Opportunity
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement With Edmonton International Airport
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Enters Second Power Provider Agreement in the Democratic Republic of the Congo
- Galenfeha, Inc. (GLFH) Broadens Oil and Gas Industry Penetration
- Growblox Sciences, Inc. (GBLX) Receives Funding to Complete Construction of Nevada Cultivation Facility
- International Stem Cell Corp. (ISCO) to Present at International Society for Cellular Therapy Annual Meeting
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) Fortune Article Highlights The One World Doll Project's Retail Success
- Pure Hospitality Solutions, Inc. (PNOW) Releases Oveedia Site Snapshots
- Save The World Air, Inc. (ZERO) Deploys Joule Heat Direct Heating System on Gathering Line for Crude Oil Pipeline in Uintah Basin
- View Systems, Inc. (VSYM) Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors